Curanex Pharmaceuticals Inc Deferred Tax Assets, Other Tax Carryforwards
Curanex Pharmaceuticals Inc (CURX) had Deferred Tax Assets, Other Tax Carryforwards of $2.06 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOtherTaxCarryforwards · last filed 2026-08-14
- 2026-06-30: Deferred Tax Assets, Other Tax Carryforwards $2.06K.
- 2025-06-30: Deferred Tax Assets, Other Tax Carryforwards $171.65K.
- 2024-12-31: Deferred Tax Assets, Other Tax Carryforwards $130.09K.
| Period end | Deferred Tax Assets, Other Tax Carryforwards |
|---|---|
| 2026-06-30 | $2.06K 10-Q · filed 2026-08-14 |
| 2025-06-30 | $171.65K 10-Q · filed 2025-09-09 |
| 2024-12-31 | $130.09K 10-Q · filed 2025-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |